Comparison of Treatment Retention Between Risperidone Long-Acting Injection and First-Generation Long-Acting Injections in Patients With Schizophrenia for 5 Years

被引：3
|
作者：
Suzuki, Hidenobu [1 ]
Hibino, Hiroyuki [2 ]
Inoue, Yuichi [3 ]
Takaya, Atsuhiko [2 ]
机构：
[1] Suzuki Clin, Dept Psychiat, Tokyo, Japan
[2] Fukui Kinen Hosp, Dept Psychiat, Yokohama, Kanagawa, Japan
[3] Shakomae Kokorono Clin, Dept Psychiat, Tokyo, Japan
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2016年 / 36卷 / 04期
关键词：
D O I：
10.1097/JCP.0000000000000533
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：405 / 406
页数：3
相关论文
共 50 条
  • [21] Comparison of treatment retention between risperidone long-acting injection, paliperidone palmitate, and aripiprazole once-monthly in elderly patients with schizophrenia
    Suzuki, Hidenobu
    Hibino, Hiroyuki
    PSYCHOGERIATRICS, 2022, 22 (01) : 159 - 160
  • [22] COST-EFFECTIVENESS OF LONG-ACTING OLANZAPINE VERSUS LONG-ACTING RISPERIDONE IN PATIENTS WITH SCHIZOPHRENIA IN SPAIN
    Dilla, T.
    O'Donohoe, P.
    Moeller, J.
    Alvarez, M.
    Sacristan, J.
    San, L.
    Happich, M.
    Tockhorn, A.
    VALUE IN HEALTH, 2011, 14 (07) : A292 - A292
  • [23] Long-term treatment with long-acting risperidone in Korean patients with schizophrenia
    Lee, Moon-Soo
    Ko, Young-Hoon
    Lee, Sang-Hoon
    Seo, Yong-Jin
    Kim, Seung-Hyun
    Joe, Sook-Haeng
    han, Cg-Su Han
    Lee, Jung-Ho
    Jung, In-Kwa
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2006, 21 (06) : 399 - 407
  • [24] Risperidone long-acting injection in the treatment of recently versus longer diagnosed patients with schizophrenia
    Lambert, T.
    Olivares, J. M.
    Tuma, I.
    Peuskens, J.
    Pecenak, J.
    bij de Weg, H.
    Eriksson, L.
    Bork, B.
    Povey, M.
    Zhao, Z.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S434 - S434
  • [25] A history of antipsychotic long-acting injections in the treatment of schizophrenia
    Crocq, M. -A.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2015, 41 (01): : 84 - 92
  • [26] Long-acting injectable risperidone: Efficacy and safety of the first long-acting atypical antipsychotic
    Kane, JM
    Eerdekens, M
    Lindenmayer, JP
    Keith, SJ
    Lesem, M
    Karcher, K
    AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (06): : 1125 - 1132
  • [27] Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia
    Eerdekens, M
    Van Hove, I
    Remmerie, B
    Mannaert, E
    SCHIZOPHRENIA RESEARCH, 2004, 70 (01) : 91 - 100
  • [28] Long-Acting Risperidone and Oral Antipsychotics in Schizophrenia
    Kwatra, Shawn G.
    Batson, Nicholas E.
    Kramer, Stephen I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (23): : 2264 - 2265
  • [29] RISPERIDONE LONG-ACTING INJECTION VS. CONVENTIONAL DEPOT INJECTIONS
    Jensen, S. O. W.
    Nielsen, J.
    Friis, R.
    Correll, C. U.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [30] Comparative Effectiveness of Risperidone Long-Acting Injectable vs First-Generation Antipsychotic Long-Acting Injectables in Schizophrenia: Results From a Nationwide, Retrospective Inception Cohort Study
    Nielsen, Jimmi
    Jensen, Signe O. W.
    Friis, Rasmus B.
    Valentin, Jan B.
    Correll, Christoph U.
    SCHIZOPHRENIA BULLETIN, 2015, 41 (03) : 627 - 636
12345